Search Results

Level up your pharmacology toolkit. 1 Ask-Me-Anything Session - Sept 18 - Trailer Published on October 28, 2025 Category Terry's Corner Pharmacology early—before your program locks into costly pathways Rethink legacy screening frameworks through modern pharmacology #GPCR #DrGPCR #Pharmacology #DrugDiscovery #Biotech #AllostericModulation #Kinetics #AssayDevelopment

Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid She is also very active within the pharmacology community and currently serves on the editorial board of the British Journal of Pharmacology. Given her expertise in GPCR pharmacology and scientific communication, she is poised to make valuable As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and

ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society. His research group uses a combination of pharmacological investigations and mathematical modeling to

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

Biochemistry: Unique Biased Agonism Profile of βCGRP on CGRP Family Receptors #GPCR #CGRP #DrugDiscovery #Pharmacology Biochemistry : Unique Biased Agonism Profile of βCGRP on CGRP Family Receptors #GPCR #CGRP #DrugDiscovery #Pharmacology

mechanisms-of-constitutive-and-agonist-induced-5-ht2b-internalization%2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology mechanisms-of-constitutive-and-agonist-induced-5-ht2b-internalization%2C-persistent-endosomal-signaling-and-paradoxical-regulation-of-agonist-pharmacology

Flash News → terrys corner from data to insight Published on July 14, 2025 Category Terry's Corner Pharmacology snapshots can reveal much more—and how predictive frameworks guide modern drug discovery. 🟢 Built for pharmacologists stronger pipelines and those rethinking legacy models. ✳️ https://www.terrykenakin.com #GPCR #DrGPCR #pharmacology

GPCR Podcast Strategic Partners GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin 1. Starting at DuPont, then BMS, Novartis, and eventually founding in vitro pharmacology departments, Sokhom Falling in Love with GPCRs GPCR pharmacology captured his scientific curiosity. Sokhom recalls how binding assays at BMS introduced him to the depth and complexity of receptor pharmacology He blends classical receptor pharmacology with biosensor technology, always adapting to new tools and

In his latest lesson, he breaks down the essential models shaping modern pharmacology. ✳️ https://www.terrykenakin.com #pharmacology #drugmechanism #kenakin #GPCR #DrGPCR Previous Next Recent

in 2006 with a BSc in Pharmaceutical Sciences from Alexandria University (Egypt) followed by MSc in Pharmacology Postdoctoral Fellow to explore novel G protein-coupled receptor (GPCR) candidates that can be targeted pharmacologically He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics

Pharmacy from Minia University in 2011 and began my career as a teaching and research assistant in Pharmacology Later, I completed my Master's degree in Pharmacology at Minia University, focusing on hydrogen sulfide's as a visiting graduate student, and in September 2022, I enrolled in the direct-entry Physiology and Pharmacology I employ a multidisciplinary approach that combines molecular pharmacology, biochemical assays, and biophysical GPCR Title: Antibodies Expand the Scope of Angiotensin Receptor Pharmacology About Meredith Skiba "Meredith

In Terry’s Corner latest lesson, discover how pharmacologic models do just that. www.ecosystem.drgpcr.com/post/what-if-you-could-predict-drug-behavior-with-just-a-snapshot #GPCR #DrGPCR #pharmacology

Paul Insel is currently a Distinguished Professor of Pharmacology and the University of California San scientific journals, including but not limited to the Journal of Clinical Investigation, Molecular Pharmacology , British Journal of Pharmacology, and American Journal of Physiology-Cell Physiology.

David Sykes " David Andrew Sykes, BSc Hons Pharmacology, MSc Molecular Biology and Biochemistry, PhD in Molecular Pharmacology & Drug Discovery. In 2014 David joined the University of Nottingham and began a part-time PhD in Molecular Pharmacology

more than 25 years of experience in drug development. have been engaged in GPCR cellular and clinical pharmacology I have participated and initiated methodologies for development of pharmacologically active anti-GPCR have published or contributed in 38 published scientific work mainly in the field of immunology and pharmacology

Home Courses Articles About Log In / Sign Up Terry's Pharmacology Corner Lost in GPCR Complexity? Matters Join Monthly AMAs with Terry Unlock 40+ Years of Expertise Master GPCRs with Precision Terry’s Pharmacology Explore : Foundational Lessons — Build Your Pharmacology Core Emerging Drug Hunter — Expand Your Edge Expert-Level Mastery — Advanced Pharmacology Live AMA Sessions with Terry

Arthur Christopoulos " Arthur Christopoulos is the Professor of Analytical Pharmacology and the Dean Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Black Analytical Pharmacology Lecturer; the GSK Award for Research Excellence and a Doctor of Laws ( Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology &

Welcome to Flash News—your fastest track to the latest updates in GPCR research, pharmacology, and biotechnology From reluctant intern to scientific leader From local signaling to spatial pharmacology From spark to Terry’s Corner was built to make advanced pharmacology practical: a space where scientists don’t just October 27, 2025 Terry's Corner Read full article Receptor pharmacology has evolved. Those who master kinetic pharmacology set the pace. 🟢 Join Terry’s Corner and sharpen your pharmacology

Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

out his Ph.D. at King’s College London, supported by an AJ Clark Ph.D. studentship from the British Pharmacological as Chief Scientific Officer, a contract research organization specializing in molecular and cellular pharmacology several pre-clinical drug discovery projects for both GPCR and non-GPCR targets, using its expertise in pharmacology

Adriano received his Bachelor of Science degree in Pharmacology in 1991 from the University of Toronto his graduate studies at the University of Toronto where he earned his MSc (1994) and Ph.D. (1998) in Pharmacology In 2004 Adriano joined the faculty of the Department of Pharmacology at Loyola University Chicago.

Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine. studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge of GPCRs pharmacology discovery and adopt data science methodology to tackle relevant scientific questions on the systems pharmacology

Pfleger trained as a pharmacologist and obtained his Ph.D. at the University of Edinburgh. I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the He is Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research and Harry He currently serves on the Board of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and is a member of the British Pharmacological Society International Advisory Group

Evi Kostenis "Pharmacist by training - PhD in Pharmacology - Postdoc at the NIH with Dr. Juergen Wess - Postdoc and Group leader in Aventis, now Sanofi, Frankfurt, Germany - Head of in vitro Pharmacology

Dmitry Veprintsev , a molecular pharmacologist at the University of Nottingham, to discuss his scientific Summary made with AI About Dmitry Veprintsev Dmitry is Professor of Molecular and Cellular Pharmacology Receptors (COMPARE), University of Nottingham, where he provides leadership in structural and biophysical pharmacology at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing his attention to structural pharmacology 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision pharmacology

Arthur Christopoulos " Arthur Christopoulos is the Professor of Analytical Pharmacology and the Dean Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Black Analytical Pharmacology Lecturer; the GSK Award for Research Excellence and a Doctor of Laws ( Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology &

Arthur Christopoulos " Arthur Christopoulos is the Professor of Analytical Pharmacology and the Dean Abel Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental and Toxicologists; the British Pharmacological Society’s Gaddum Memorial Award; the IUPHAR Sir James Black Analytical Pharmacology Lecturer; the GSK Award for Research Excellence and a Doctor of Laws ( Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology &

Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched at the Institute of Pharmacology He received a Ph.D. in pharmacology in 1992 from the Russian Academy of Medical Sciences and an M.D. Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology

Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology. In addition to paradigm shifts including inverse agonism, biased signaling, and pharmacological chaperones fellow of the Royal Society of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology

papers on lipid-rich domains and GPCR–G protein compartmentalization reframed her view of receptor pharmacology papers on lipid-rich domains and GPCR–G protein compartmentalization reframed her view of receptor pharmacology